Entelo
2 known investors
Entelo Bio operates an insights platform that analyzes disease biology at high resolution to support precision medicine. The company focuses on applications in human resilience.
Also known as Caeruleus · Entelo Bio
Investors · 2
Company profile
researched Aug 2026Entelo Bio is a biotechnology company whose insights platform is positioned to decode disease complexity at high resolution and reveal underlying biology, with the stated aim of enabling precision medicine in the area it describes as "Human Resilience."
The company has also been described as a gene sequencing company working to reduce the error rate and cost of long-read single-cell sequencing, combining chemistry with machine learning to produce results that otherwise require only a low number of cells.
▸Full profile — market position, technology
Market position
Entelo Bio is an early-stage biotech company associated with the University of Oxford and backed by The Creator Fund, which lists the company under its biotech investments with an investment year of 2022.
Technology
The company's approach couples advanced chemistry with machine learning applied to long-read single-cell gene sequencing, targeting lower error rates and reduced cost relative to existing methods, which are described as achievable only with a low number of cells. On its own site, the company frames this capability as an insights platform that resolves disease complexity in order to support precision medicine.
Compiled by commissioned research from 7 cited public sources — announcements, filings, and press listed under research sources below.
Timeline · 1
launches, deals, and filingsThe Creator Fund lists Entelo Bio as a biotech portfolio company originating from the University of Oxford, with an investment year of 2022 and status listed as active.
Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.
▸Research sources · 7
primary sources listed
- Enteloentelo.bio · web
7 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does Entelo do?
- Entelo Bio is a biotech company developing a disease-biology insights platform aimed at precision medicine in human resilience.
- Who are Entelo's investors?
- Entelo's investors include HAWKTAIL, Ananda Impact Ventures.